+86-28-82633987
ISO ISO
ISO 17025 ISO 17025
usp usp
EN
CN EN

SLC2A1

Catalog No Product Description CAS No. Purity Structural Formula
BP1669
Fuscaxanthone C
1-Hydroxy-3,6,7-trimethoxy-2,8-diprenylxanthone is a member of xanthones. Fuscaxanthone C is a natural product from Garcinia mangostana.
15404-76-9 98% Fuscaxanthone C
BP2009
Sarracenin
Sarracenin is a member of dioxanes.
59653-37-1 98% Sarracenin
BP2316 1192850-63-7 98% 6-Iodo 5,7,3',4',5'-Pentamethoxyflavone
BP2029
Arjungenin
Arjungenin shows β-glucuronidase inhibitory activity, it shows antiviral, and anti-inflammatory activities. Arjungenin exhibits moderate antibacterial activity against Staphylococcus aureus, Escherichia coli and Enterococcus faecalis (MICs within a range of 64 and 256 ug/mL). Arjungenin shows significant protection against domoic acid induced toxicity in Caco-2 cell line.
58880-25-4 98% Arjungenin
BP1793
Galgravin
Galgravin has anti-inflammatory, and neuroprotective effects, it can promote neuronal survival and neurite outgrowth, protect hippocampal neurons against amyloid beta peptide (Abeta25-35)-induced cytotoxicity, and protect against neuronal death from 1-methyl-4-phenylpyridinium ion (MPP+)-induced toxicity in cultured rat hippocampal neurons. Galgravin has cytotoxic activity against human leukemia (HL-60) tumor cells with the IC50 value of 16.5 ± 0.8 ug/mL. Galgravin also can inhibit bone resorption and may offer a novel compounds for the development of drugs to treat bone-destructive diseases such as osteoporosis. Galgravin is a member of the class of aryltetrahydrofurans carrying two 3,4-dimethoxyphenyl substituents at positions 2 and 5 as well as two methyl groups at positions 3 and 4. It has a role as a platelet aggregation inhibitor, a bone density conservation agent, a neuroprotective agent and a plant metabolite. It is a lignan, a ring assembly, an aryltetrahydrofuran and a dimethoxybenzene.
528-63-2 98% Galgravin
BP5183
Aloenin B
Aloenin and aloe-emodin are active principles for inhibition of c-ADH and c-ALDH activities in vitro.
106533-41-9 Aloenin B
BP5646 2423917-90-0 Ophiopogonside A
BP4777 1072789-38-8 98% Hirudonucleodisulfide B
BP3188
Hosenkoside B
Hosenkoside B is a natural product from Impatiens balsamina L.
156764-82-8 98% Hosenkoside B
BP0921 88497-88-5 Manassantin B
BP4788
Maltotriose
Maltotriose is a maltotriose trisaccharide in which the glucose residue at the reducing end is in the aldehydo open-chain form.
1109-28-0 98% Maltotriose
BP3156
Ganoderic acid D
Ganoderic acid D treatment for 48h inhibits the proliferation of HeLa human cervical carcinoma cells with an IC(50) value of 17.3 +/- 0.3 microM.
108340-60-9 98% Ganoderic acid D
BP1774
Artemitin
Artemetin is an ether and a member of flavonoids.
479-90-3 98% Artemitin
BP2273 942950-94-9 98% Ganoderenic acid K
SBP03783 14930-96-2 Cytochalasin B
BP1865
Ganoderic acid C6
Ganoderic acid C6 has antinociceptive activity.
105742-76-5 98% Ganoderic acid C6
BP1151
Prosapogenin A
Prosapogenin A has anti-obesity, and immunomodulating effects, it exhibits cytotoxic activity against the cancer cell line K562 in vitro.
19057-67-1 98% Prosapogenin A
BP2023
Trans Sodium Crocetinate
Trans sodium crocetinate (TSC) has been developed to enhance the delivery of oxygen to hypoxic tissues, TSC with temozolomide and radiation therapy for glioblastoma multiforme. TSC provides neuroprotection against cerebral ischemia and reperfusion in obese mice, it improves outcomes in rodent models of occlusive and hemorrhagic stroke.
591230-99-8 98% Trans Sodium Crocetinate
BP0260
Beta,beta-Dimethylacrylshikonin
Beta,beta-Dimethylacrylshikonin is a hydroxy-1,4-naphthoquinone.
24502-79-2 98% Beta,beta-Dimethylacrylshikonin
BP2015
Gambogellic acid
Gambogellic acid has cytotoxic activity, it exhibits inhibitory effect against SMMC-7221cell and A549 cell.
173867-04-4 98% Gambogellic acid